Patients Living With Diabetes Voice Eagerness for ‘Finger-Prick’ Alternative in Global Glucose Monitoring Survey
Global results show 90% of patients are in favor of a saliva-based glucose testNEW YORK, June 08, 2021 (GLOBE NEWSWIRE)…
Pharmaceuticals, Biotechnology and Life Sciences
Global results show 90% of patients are in favor of a saliva-based glucose testNEW YORK, June 08, 2021 (GLOBE NEWSWIRE)…
Topline readout of data from NORSE TWO targeted for calendar Q3 2021New Biologics License Application (BLA) filing anticipated in calendar…
SEATTLE, June 08, 2021 (GLOBE NEWSWIRE) — SEngine Precision Medicine, a precision oncology company that pre-tests drugs on patient-derived tumor…
Novel arenaviral therapeutic HB-200 generates outstanding tumor antigen-specific CD8+ T cell responses (average of 6 percent and up to 40…
EMERYVILLE, Calif., June 07, 2021 (GLOBE NEWSWIRE) — Biofacturing leader Zymergen today announced the company will be participating in the upcoming…
101 College Street Groundbreaking Ceremony Arvinas participates in a ceremonial groundbreaking for 101 College Street, a new 525,000-square-foot-building to be…
CAMBRIDGE, Mass. and LONDON, June 07, 2021 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA) announced today that Saurabh Saha,…
A Quorum Has Been Achieved to Reconvene Annual Meeting on Thursday June 10, 2021 Polls Remain Open, Shareholders are Urged…
CARLSBAD, Calif., June 07, 2021 (GLOBE NEWSWIRE) — Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology company developing treatments for degenerative…
CARLSBAD, Calif., June 07, 2021 (GLOBE NEWSWIRE) — Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology company developing treatments for degenerative…